159 related articles for article (PubMed ID: 38475759)
1. Palliative primary tumor resection may not offer survival benefits for patients with unresectable metastatic colorectal neuroendocrine neoplasms, one multicenter retrospective cohort study.
Yu G; Liu S; Wang Z; Liu Q; Ren H; Hu W
BMC Surg; 2024 Mar; 24(1):85. PubMed ID: 38475759
[TBL] [Abstract][Full Text] [Related]
2. Survival outcomes following primary tumor resection for patients with incurable metastatic colorectal carcinoma: Experience from a single institution.
Lau JW; Chang HS; Lee KY; Gwee YX; Lee WQ; Chong CS
J Dig Dis; 2018 Sep; 19(9):550-560. PubMed ID: 30117288
[TBL] [Abstract][Full Text] [Related]
3. Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent.
Wong SF; Wong HL; Field KM; Kosmider S; Tie J; Wong R; Tacey M; Shapiro J; Nott L; Richardson G; Cooray P; Jones I; Croxford M; Gibbs P
Clin Colorectal Cancer; 2016 Sep; 15(3):e125-32. PubMed ID: 26803709
[TBL] [Abstract][Full Text] [Related]
4. Tumor Differentiation is the Dominant Prognostic Factor for Patients with Colorectal Neuroendocrine Neoplasms with Distant Metastasis.
Wang Z; Shi S; Ren H; Liu Q
Int J Endocrinol; 2022; 2022():1720624. PubMed ID: 36578535
[TBL] [Abstract][Full Text] [Related]
5. Palliative resection of the primary tumour improves survival in incurable metastatic colorectal cancer.
Inci K; Nilsson B; Lindskog S; Giglio D
ANZ J Surg; 2023 Nov; 93(11):2680-2685. PubMed ID: 37489624
[TBL] [Abstract][Full Text] [Related]
6. Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with liver metastasis: a preliminary population-based analysis.
Zhao J; Zhu J; Sun R; Huang C; Yuan R; Zhu Z
BMC Cancer; 2021 May; 21(1):503. PubMed ID: 33957871
[TBL] [Abstract][Full Text] [Related]
7. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
Zheng M; Li Y; Li T; Zhang L; Zhou L
Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
[TBL] [Abstract][Full Text] [Related]
8. An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients.
Liang L; Tian J; Yu Y; Wang Z; Peng K; Liu R; Wang Y; Xu X; Li H; Zhuang R; Cui Y; Zhu C; Liu T
Cell Physiol Biochem; 2018; 50(2):768-782. PubMed ID: 30308491
[TBL] [Abstract][Full Text] [Related]
9. Resection of the Primary Tumor Improves the Survival of Patients With Stage IV Gastric Neuroendocrine Carcinoma.
Li Z; Ren H; Wang T; Zhang X; Zhao L; Sun C; Niu P; Guo C; Chen Y; Zhao D
Front Oncol; 2022; 12():930491. PubMed ID: 35912176
[TBL] [Abstract][Full Text] [Related]
10. Survival Benefit of Primary Tumor Resection Combined With Chemotherapy in Patients With Unresectable Colorectal Mucinous Adenocarcinoma With Liver Metastasis.
Liao SW; Zhan JQ; Liu CT; Yu HT; Wen MJ
Am J Clin Oncol; 2024 Jan; 47(1):30-39. PubMed ID: 38148710
[TBL] [Abstract][Full Text] [Related]
11. Impact of primary tumor resection in the management of metastatic well-differentiated neuroendocrine tumors of the small bowel and pancreas.
Russo A; DiPeri T; Dumitra T; Tseng J; Pletcher E; Justo M; Chen C; Nissen N; Amersi F; Gong J; Hendifar A; Gangi A
J Neuroendocrinol; 2024 May; ():e13399. PubMed ID: 38760997
[TBL] [Abstract][Full Text] [Related]
12. Surgical resection and survival outcomes in metastatic young adult colorectal cancer patients.
Arhin ND; Shen C; Bailey CE; Matsuoka LK; Hawkins AT; Holowatyj AN; Ciombor KK; Hopkins MB; Geiger TM; Kam AE; Roth MT; Lebeck Lee CM; Lapelusa M; Dasari A; Eng C
Cancer Med; 2021 Jul; 10(13):4269-4281. PubMed ID: 34132476
[TBL] [Abstract][Full Text] [Related]
13. Impact of Primary Tumor Resection on Mortality in Patients with Stage IV Colorectal Cancer with Unresectable Metastases: A Multicenter Retrospective Cohort Study.
Kawamura H; Ogawa Y; Yamazaki H; Honda M; Kono K; Konno S; Fukuhara S; Yamamoto Y
World J Surg; 2021 Oct; 45(10):3230-3239. PubMed ID: 34223985
[TBL] [Abstract][Full Text] [Related]
14. Tumor Macroscopic Morphology Is an Important Prognostic Factor in Predicting Chemotherapeutic Efficacy and Clinical Outcomes of Patients With Colorectal Neuroendocrine Neoplasms, One Multicenter Retrospective Cohort Study.
Wang Z; An K; Li R; Liu Q
Front Endocrinol (Lausanne); 2021; 12():801741. PubMed ID: 34987482
[TBL] [Abstract][Full Text] [Related]
15. Primary Tumor Resection Offers Survival Benefit in Patients with Metastatic Midgut Neuroendocrine Tumors.
Polcz M; Schlegel C; Edwards GC; Wang F; Tan M; Kiernan C; Solórzano CC; Idrees K; Parikh A; Bailey CE
Ann Surg Oncol; 2020 Aug; 27(8):2795-2803. PubMed ID: 32430752
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit of primary tumor resection for gastric cancer with liver metastasis: A propensity score-matched, population-based study.
Wu J; Yu J; Chen Z; Zhu H; Zhong C; Liang Y; Mai Z; Lin Z; Wan Y; Li G
Front Oncol; 2022; 12():1039086. PubMed ID: 36465378
[TBL] [Abstract][Full Text] [Related]
17. The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy.
Yeom SS; Lee SY; Kwak HD; Kim CH; Kim YJ; Kim HR
Medicine (Baltimore); 2020 Feb; 99(7):e19258. PubMed ID: 32049866
[TBL] [Abstract][Full Text] [Related]
18. Survival outcome of palliative primary tumor resection for colorectal cancer patients with synchronous liver and/or lung metastases: A retrospective cohort study in the SEER database by propensity score matching analysis.
Chen X; Hu W; Huang C; Liang W; Zhang J; Wu D; Lv Z; Li Y; Luo Y; Liang Z; Wang M; Wang J; Yao X
Int J Surg; 2020 Aug; 80():135-152. PubMed ID: 32634480
[TBL] [Abstract][Full Text] [Related]
19. Is primary tumor resection associated with a longer survival in colon cancer and unresectable synchronous metastases? A 4-year multicentre experience.
de Mestier L; Neuzillet C; Pozet A; Desot E; Deguelte-Lardière S; Volet J; Karoui M; Kianmanesh R; Bonnetain F; Bouché O
Eur J Surg Oncol; 2014 Jun; 40(6):685-91. PubMed ID: 24630774
[TBL] [Abstract][Full Text] [Related]
20. Analysis of survival benefit from primary tumor resection and individualized prediction of overall survival for lung cancer patients with bone metastasis: Worth it or not?
Tong Y; Jiang L; Gong Y; Zhu D; Zhao D
Asian J Surg; 2024 Jan; 47(1):333-349. PubMed ID: 37741753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
